Announcements Trials
Browse Landscape

Phase

Phase 1/2 1Phase 1 1

Status

Completed 63Terminated 17Unknown 11Recruiting 9Suspended 2Not yet recruiting 2No longer available 1Active not recruiting 1

Sponsor Class

OTHER 3INDUSTRY 2

Study Type

Interventional 2

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 72Breast Neoplasms 52Colorectal Neoplasms 46Neoplasms 37Multiple Myeloma 33Advanced Solid Tumors 32Recurrence 29Prostatic Neoplasms 29Pancreatic Neoplasms 27Ovarian Neoplasms 26Lung Neoplasms 26Carcinoma, Hepatocellular 26Neoplasm Metastasis 24Advanced Solid Tumor 20Small Cell Lung Carcinoma 19Leukemia, Myeloid, Acute 19Melanoma 17Endometrial Neoplasms 17Triple Negative Breast Neoplasms 14Stomach Neoplasms 14Lymphoma, Follicular 14Lymphoma 13Glioma 13Glioblastoma 13Lymphoma, B-Cell 12Squamous Cell Carcinoma of Head and Neck 11Uterine Cervical Neoplasms 10Head and Neck Neoplasms 10Leukemia 9Esophageal Neoplasms 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Not yet recruiting × INDUSTRY × Advanced Cancer × Clear all
NCT07605962 2026-05-26

Phase 1/2 Study of UI-102 in Selected Advanced Cancers

United Immunity, co., Ltd.

Phase 1/2 Not yet recruiting
140 enrolled

Advanced Cancer

NCT07291050 2025-12-18

A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of TQB3217 Tablets in Subjects With Advanced Malignant Tumors

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Phase 1 Not yet recruiting
40 enrolled

Advanced Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡